SCHEMBL7468135

SCHEMBL7468135

c1ccc(CN2CC[C@H](Oc3cccnc3-c3cccs3)C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 4/20 0.53
▸ KDM4E B2RXH2 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ DRD2 P14416 4/20 0.43
▸ DRD4 P21917 4/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ SCN8A Q9UQD0 8/20 0.43
▸ SCN1A P35498 3/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17456046 0.84 MCHR1 (0.53) MCHR1KDM4EL3MBTL1NPC1DRD2
SCHEMBL7470506 0.81 NOS3 (0.42) L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL7466317 0.80 NOS3 (0.42) L3MBTL1MEN1KMT2A
SCHEMBL17456049 0.80 MCHR1 (0.57) MCHR1KDM4EL3MBTL1NPC1DRD2
SCHEMBL17455968 0.77 SMN1; SMN2 (0.53) MCHR1DRD2DRD4SMN1; SMN2LMNA
SCHEMBL7468132 0.74 ROCK1 (0.48) MCHR1KDM4EL3MBTL1DRD2DRD4
SCHEMBL10607853 0.73 MCHR1 (0.57) MCHR1KDM4EDRD2DRD4SMN1; SMN2
SCHEMBL17455980 0.73 SMN1; SMN2 (0.58) MCHR1DRD2DRD4SMN1; SMN2SCN8A
SCHEMBL17455974 0.72 SMN1; SMN2 (0.50) MCHR1DRD2DRD4SMN1; SMN2SCN8A
SCHEMBL3886322 0.72 MCHR1 (0.59) MCHR1SMN1; SMN2SCN8AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151712-A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission LIN NAN-HORNG (US) 2002-10-17 — — US disclosed
EP-1212319-A2 3-PYRROLIDINYLOXY-3'-PYRIDYL ETHER COMPOUNDS USEFUL FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION Abbott Laboratories (US) 2002-06-12 — — EP disclosed
WO-2001019817-A2 3-PYRROLIDINYLOXY-3'-PYRIDYL ETHER COMPOUNDS USEFUL FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LABORATORIES (US) 2001-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151712-A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission GAP43, SLC18A2, GABRE MCHR1 919/4885KDM4E 1251/4885L3MBTL1 3582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback